Organizers are the German Society for Biomedical Engineering within VDE (DGBMT), the Friedrich Schiller University of Jena, the Ilmenau University of Technology and the University of Applied Sciences Jena, supported by medways - the industry association for Medical Technology and Biotechnology.
The conference, conducted in German and English, will address medical experts, engineers and scientists and be accompanied by a trade exhibition as well as workshops, networking and recruiting events. Contributions from all fields of biomedical technology can be submitted by March 15, 2012.Call for Papers
Please submit your contributions (structured abstracts in English, max. 300 words) online under Papers at www.bmt2012.de by March 15, 2012. In addition, students participating in the DGBMT Student Competition 2012 can also submit the results of their final papers, with the exception of dissertations, as posters or presentations in German or English. The best conference papers will receive certificates and prizes.
The first place will be awarded 1,000 euros, the second place 600 euros and the third place 400 euros. Additional details on the competition are available at: www.bmt2012.de.
All accepted abstracts/papers will be published online as a free-access supplement to the regular annual issue of Biomedical Engineering (de Gruyter) and be prepared by de Gruyter for a listing in PubMed.
Press contact: Melanie Mora, Tel. +49 (0)69 6308461, email@example.com
Melanie Mora | VDE
Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened
19.05.2020 | Leibniz-Institut für ökologische Raumentwicklung e. V.
Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021
07.04.2020 | Fraunhofer-Institut für Produktionstechnologie IPT
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering